Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 109.55
+1.05 (0.97%)
Sep 5, 2025, 5:35 PM CET
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
€335,956
Profits / Employee
€45,329
Market Cap
47.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59,020 | -3,888 | -6.18% |
| Dec 31, 2023 | 62,908 | -1,324 | -2.06% |
| Dec 31, 2022 | 64,232 | 3,898 | 6.46% |
| Dec 31, 2021 | 60,334 | 2,207 | 3.80% |
| Dec 31, 2020 | 58,127 | 1,056 | 1.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
| SCHOTT Pharma AG & Co. KGaA | 4,690 |
Merck KGaA News
- 1 day ago - Merck Foundation CEO Meets Zimbabwe First Lady & 13 First Ladies of Africa and Asia at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Strategy to Build Healthcare Capacity and Support Girl Education - Business Upturn
- 2 days ago - Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Financial Post
- 2 days ago - Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Business Wire
- 3 days ago - Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector - Business Wire
- 8 days ago - mRNA Biotechs - Long-Term Value Risks Abound - Seeking Alpha
- 18 days ago - European Commission Grants Approval of OGSIVEO (nirogacestat) for the Treatment of Adults with Desmoid Tumors - Wallstreet:Online
- 4 weeks ago - Merck KGaA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Merck KGaA (MKGAF) Q2 2025 Earnings Call Transcript - Seeking Alpha